Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Food Fight: Why Kellogg Stock Beats General Mills

By Will Ashworth, InvestorPlace Contributor

If Kellogg (K) looks a little dirtier than General Mills (GIS), it's because of all the hard work the company is putting into strengthening its business.

Take a Break from Hess, Pick Up Marathon

By Will Ashworth, InvestorPlace Contributor

While Hess and Marathon Oil had tough third quarters, one company's recent oil-field acquisitions bode well. See which stock is the better buy.

CF Industries Sows the Seeds of Interest

By Will Ashworth, InvestorPlace Contributor

Agricultural biotech specialist Monsanto (MON) is reliable, but fertilizer company CF Industries (CF) is much better poised for growth.

Betting on the Recovery? Back Paychex, Skip ADP

By Will Ashworth, InvestorPlace Contributor

Not everyone will ride economic recovery the same way -- Paychex's (PAYX) ability to make more with less, as well as its dividend, make it more attractive.

MAKO Surgical Has Promising Potential

By Will Ashworth, InvestorPlace Contributor

More than a decade after its IPO, Intuitive Surgical (ISRG) remains healthy, but newcomer MAKO Surgical (MAKO) is primed for growth.

Load More